Tickers

1. Composite Trajectory Verdict

For a bank, the income statement (net interest income, credit costs, efficiency) and balance sheet (asset quality, capital, funding) carry roughly equal weight in assessing financial trajectory, as profitability and balance-sheet resilience are interdependent in banking.

Composite Trajectory: Mixed

The annual income statement shows consistent improvement: net income rose from $419.3M (2023) to $479.4M (2024) to $542.8M (2025) (10-K 2025-12-31, MD&A Overview); net interest margin expanded from 2.78% to 2.93% to 3.22% (tax equivalent) (10-K 2025-12-31, MD&A Net Interest Income); and the efficiency ratio improved from 50.26% to 48.43% to 44.55% (10-K 2025-12-31, MD&A Efficiency Ratio). However, the balance sheet shows deteriorating asset quality: nonperforming assets nearly doubled from $81.5M to $150.8M (10-K 2025-12-31, MD&A Nonperforming Assets) while the allowance for credit losses fell from $351.8M to $333.7M (10-K 2025-12-31, MD&A Allowance for Credit Losses), driving the coverage ratio down from 463.9% to 242.7% (10-K 2025-12-31, MD&A Nonperforming Assets). Total loans declined 1.6% in 2025 after 4.6% growth in 2024 (10-K 2025-12-31, MD&A Loan Portfolio). Cash generation remained strong ($550M operating cash flow in 2025) but cash balances fell 11.4% to $1.75B (10-K 2025-12-31, MD&A Liquidity).

2. Red Flags

• Nonperforming assets surged 85% to $150.8M at 12/31/2025 from $81.5M at 12/31/2024, while the allowance for credit losses decreased 5.1% to $333.7M from $351.8M, cutting the allowance-to-nonperforming-loans coverage ratio from 463.9% to 242.7% (10-K 2025-12-31, MD&A Nonperforming Assets; MD&A Allowance for Credit Losses).
• Net charge-offs rose to $18.1M in 2025 from $14.6M in 2024 despite zero provision for credit losses in 2025 (vs. $9.1M in 2024 and $18.5M in 2023) (10-K 2025-12-31, MD&A Provision for Credit Losses).
• Total loans contracted 1.6% ($343.8M) in 2025 after growing 4.6% in 2024 (10-K 2025-12-31, MD&A Loan Portfolio).
• Cash and cash equivalents declined 11.4% ($224.7M) to $1.75B at 12/31/2025 (10-K 2025-12-31, MD&A Liquidity).
• Uninsured deposits stood at $12.45B (43.7% of total deposits) at 12/31/2025, up from $11.88B at 12/31/2024 (10-K 2025-12-31, MD&A Deposits).
• Short-term wholesale funding reliance: $1.95B in FHLB advances (3.63% weighted average rate) and $201.2M in repurchase agreements at 12/31/2025 (10-K 2025-12-31, MD&A Other Borrowings).
• Pending Stellar Bancorp acquisition valued at ~$2.0B (0.3803 shares + $11.36 cash per share) introduces integration risk and potential share dilution (10-K 2025-12-31, MD&A Subsequent Events).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Net income increased each year: $419.3M (2023) → $479.4M (2024) → $542.8M (2025) (10-K 2025-12-31, MD&A Overview). Net interest income grew steadily: $956.4M → $1,026.5M → $1,081.5M (10-K 2025-12-31, MD&A Net Interest Income). Net interest margin (tax equivalent) expanded from 2.78% to 2.93% to 3.22% (10-K 2025-12-31, MD&A Net Interest Income). Noninterest income rose from $153.3M to $165.8M to $168.3M (10-K 2025-12-31, MD&A Noninterest Income). Noninterest expense declined 2.5% to $556.2M in 2025 after a 2.5% increase in 2024 (10-K 2025-12-31, MD&A Noninterest Expense). The efficiency ratio improved from 50.26% to 48.43% to 44.55% (10-K 2025-12-31, MD&A Efficiency Ratio). ROA rose from 1.08% to 1.21% to 1.42%; ROE from 6.03% to 6.56% to 7.14% (10-K 2025-12-31, MD&A Overview). Provision for credit losses fell to zero in 2025 from $9.1M in 2024 and $18.5M in 2023 (10-K 2025-12-31, MD&A Provision for Credit Losses).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Operating cash flow was strong at $550.0M in 2025 (10-K 2025-12-31, MD&A Liquidity). However, cash and cash equivalents declined 11.4% to $1.75B at